BKV ORATION ($BKV) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of $0.29 per share, missing estimates of $0.31 by $0.02. The company also reported revenue of $259,910,000, missing estimates of $264,503,415 by $-4,593,415.
You can see Quiver Quantitative's $BKV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BKV ORATION Insider Trading Activity
BKV ORATION insiders have traded $BKV stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $BKV stock by insiders over the last 6 months:
- CHRISTOPHER P KALNIN (Chief Executive Officer) has made 0 purchases and 4 sales selling 300,000 shares for an estimated $8,131,958.
- LINDSAY B LARRICK (Chief Legal and Admin Officer) has made 0 purchases and 6 sales selling 63,374 shares for an estimated $1,524,308.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BKV ORATION Hedge Fund Activity
We have seen 110 institutional investors add shares of BKV ORATION stock to their portfolio, and 44 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DME CAPITAL MANAGEMENT, LP added 1,287,943 shares (+inf%) to their portfolio in Q4 2025, for an estimated $34,967,652
- COOPER CREEK PARTNERS MANAGEMENT LLC added 1,225,292 shares (+265.4%) to their portfolio in Q4 2025, for an estimated $33,266,677
- MEREWETHER INVESTMENT MANAGEMENT, LP added 799,700 shares (+91.2%) to their portfolio in Q4 2025, for an estimated $21,711,855
- AVENTAIL CAPITAL GROUP, LP removed 583,039 shares (-66.6%) from their portfolio in Q4 2025, for an estimated $15,829,508
- UBS GROUP AG added 545,296 shares (+217.3%) to their portfolio in Q4 2025, for an estimated $14,804,786
- ZIMMER PARTNERS, LP added 499,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,547,850
- BLACKROCK, INC. added 447,052 shares (+34.9%) to their portfolio in Q4 2025, for an estimated $12,137,461
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BKV ORATION Analyst Ratings
Wall Street analysts have issued reports on $BKV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 12/12/2025
- Barclays issued a "Overweight" rating on 11/13/2025
To track analyst ratings and price targets for BKV ORATION, check out Quiver Quantitative's $BKV forecast page.
BKV ORATION Price Targets
Multiple analysts have issued price targets for $BKV recently. We have seen 5 analysts offer price targets for $BKV in the last 6 months, with a median target of $32.0.
Here are some recent targets:
- Leo Mariani from Roth Capital set a target price of $31.0 on 01/07/2026
- Nitin Kumar from Mizuho set a target price of $36.0 on 12/12/2025
- Betty Jiang from Barclays set a target price of $32.0 on 11/13/2025
- Tim Rezvan from Keybanc set a target price of $30.0 on 11/11/2025
- Biju Perincheril from Susquehanna set a target price of $33.0 on 11/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
